• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Access to Healthcare

Improving lives through community-based care

Bringing healthcare closer to where people live, work and shop can effectively tackle hypertension – the most deadly noncommunicable disease.

Dec 07, 2018

Every year, over 10 million people around the world die of hypertension – a condition often referred to as the “silent killer” because of its lack of symptoms. When left unaddressed, it can lead to heart disease, stroke or kidney failure.

Hypertension control rates vary significantly between countries. For example, in Ghana, just 4%1 of people with dangerously high blood pressure have their condition controlled, compared to 53%2 in the US.

The rise of noncommunicable diseases (NCDs) like hypertension is especially challenging for low- and middle-income countries, where many healthcare systems are overstretched and often set up primarily to fight infectious diseases.  

Evelyn is a nurse in rural Ghana who specializes in cardiovascular disease.
Evelyn is a cardiovascular nurse working in rural Ghana, where high-fat diets, smoking and sedentary lifestyles contribute to high blood pressure. “There is diabetes alongside strokes, [and] sudden deaths due to heart attacks and kidney failure. These are all too common in Ghana,” she says.
(Dr. Alex Kumar/Novartis Foundation)

In 2015, the Novartis Foundation and partners launched an innovative approach to managing hypertension in a peri-urban region of Ghana. Working with the Ghana Health Service, the London School of Hygiene & Tropical Medicine, and FHI 360, the community-based hypertension management project (ComHIP) tested a new model to detect, diagnose and treat hypertension as early as possible by enabling local shops and businesses to offer blood pressure screening. 

Dorothy is a licensed chemical seller involved in ComHIP.
Dorothy is a licensed chemical seller. The ComHIP program trained her to test customers for high blood pressure, picking up new cases among people who may not be able to access standard medical services and therefore would have gone undiagnosed. (Dr. Alex Kumar/Novartis Foundation)

Digital technology connected people who screened positive for hypertension at the new screening points with healthcare workers. SMS messages helped patients adhere to medication, diet and exercise regimens – ultimately saving lives.

This demonstrates how simple digital health tools that use existing technology can make an enormous difference to people’s health.

A doctor based at St. Martin’s Hospital holds a blood pressure monitor.
Bernard, a physician’s assistant at St. Martin’s Hospital in Ghana, uses ComHIP’s digital platform to review the records of people referred to him with high blood pressure. “It’s a rush to find [people] in time to prevent a stroke,” he says. (Dr. Alex Kumar/Novartis Foundation)

The ComHIP results show how successfully community-based care can address chronic conditions like hypertension. For people enrolled in the program for over a year, average hypertension control rates rose from 36% to 71%, with an average reduction of 12 mm Hg in systolic blood pressure and 7 mm Hg in diastolic blood pressure.

ComHIP made it easier for patients to access care, removing the need to travel to hospitals or clinics. This saves time and money for patients, and reduces pressure on overstretched healthcare systems.

A woman at St. Martin’s Hospital has her blood pressure monitored.
Veronica was diagnosed with high blood pressure through ComHIP, and her condition is now under control. While visiting St. Martin’s Hospital, she told us about one of her younger neighbors who became disabled after a stroke caused by high blood pressure. No one knew about her condition until it was too late.
(Dr. Alex Kumar/Novartis Foundation)

The ComHIP results demonstrate the huge potential of community-based care and suggest that this method of bringing care closer to where people live, work and shop could save millions of lives if replicated in other countries and for other NCDs.

Two nurses involved in the ComHIP project

  1. Lloyd-Sherlock P., Beard J., Minicuni N., Ebrahim S., Chatterji S. Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control, International Journal of Epidemiology, 2013 [p.126]. 
  2. Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open 2013;3:e003423. doi: 10.1136/bmjopen-2013-003423

Shareline

Learn how community-based care can address chronic conditions like #hypertension.
Tweet Tweetpopo

The Novartis Foundation

The Novartis Foundation is pioneering innovative approaches and using digital technology to tackle noncommunicable diseases and strengthen healthcare systems.

Learn more

Tags: 
Access to Healthcare, Chronic Illness, Global Health Partnerships, Mobile Devices, Reimagine Medicine
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Dr. Theophile Tuyisabe standing next to his patients smiling at him
Access to Healthcare

Meet a visionary who beat the odds to realize his vision of inclusive eye care

Access to Healthcare

Chagas disease: Breaking the silence

Sandoz in Kalwe, India ensures multidrug therapy (MTD) supply to WHO to fight leprosy
Access to Healthcare

Ensuring medicine supply to patients during COVID-19

You are here

  1. Home ›
  2. Stories ›
  3. Access healthcare

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.